Is Sodium Bicarbonate Injection in shortage?
Yes. Sodium Bicarbonate Injection is on FDA’s drug shortage list (unavailable), last updated Oct 6, 2026.
Why it’s in shortage
- Demand increase for the drug
- Other
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 63323-083-05)
Check wholesalers for inventory.
Maker contact: 888-386-1300
- Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 63323-089-50)
Check wholesalers for inventory
Maker contact: 888-386-1300
- Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 76329-3352-1)
Available on allocation
Maker contact: 800-423-4136
- Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5001-5)
Maker contact: 828-758-5474 ext. 154
- Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5011-4)
Maker contact: 828-758-5474 ext. 154
- Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 51754-5012-4)
Maker contact: 828-758-5474 ext. 154
- Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 81298-7620-3)
Maker contact: 833-268-5559
- Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-01)
Limited Supply Available. Next Delivery: May 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay
Maker contact: 844-646-4398
- Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02)
Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
Maker contact: 844-646-4398
- Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-14)
Maker contact: 844-646-4398
- Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-35)
Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay
Maker contact: 844-646-4398
- Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 0409-4900-14)
Discontinuation of the manufacture of the drug
Maker contact: 844-646-4398
- Sodium Bicarbonate, Injection, 75 mg/1 mL (NDC 0409-4916-14)
Discontinuation of the manufacture of the drug
Maker contact: 844-646-4398
- Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 0409-5534-14)
Discontinuation of the manufacture of the drug
Maker contact: 844-646-4398
- Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 0409-6637-14)
Discontinuation of the manufacture of the drug
Maker contact: 844-646-4398
FDA recalls of Sodium Bicarbonate
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Sodium Bicarbonate Injection:
- PFIZER INC recalls Vial Label: 8.4% Sodium Bicarbonate Injection, USP, 50mEq/50 mL (1 mEq/mL), Rx only, Hospira, Inc., Lake Forest, IL
- Exela Pharma Sciences LLC recalls 4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10 mL (0.5 mEq/mL), For Intravenous Use Only, 10 mL Single Dose Vial, Rx
- Exela Pharma Sciences LLC recalls 8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1 mEq/mL), 25 x 50 mL Single Dose Vials per carton, For
- Bausch Health Companies, Inc. recalls Omeprazole and Sodium Bicarbonate For Oral Suspension 40mg/1,680mg, This packet contains 40mg of omeprazole and 1,680mg
- Pfizer Inc. recalls 8.4 % Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, Rx
- Exela Pharma Sciences LLC recalls 8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1mEq/mL), a) 20x50 mL Single Dose Vials (Vial NDC 51754-5001-1;
- Exela Pharma Sciences LLC recalls 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20
- Exela Pharma Sciences LLC recalls 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20
- Lupin Pharmaceuticals Inc. recalls GaviLyte -C (Polyethylene Glycol 3350, 240 g) and electrolytes for Oral Solution, USP with flavor pack NDC# 43386-060-19
- Mckesson Medical-Surgical Inc. Corporate Office recalls Sodium Bicarbonate Tablets, 600 mg, 1000-count bottle, MFG: Major Pharma, NDC 0536-1047-10
- Mckesson Medical-Surgical Inc. Corporate Office recalls E-Z-Gas II, Effervescent Granules, Net Weight: 4 g, 50 packets per box, MFG: Bracco Diagnostics Inc., NDC 0270-9020-01
- Novel Laboratories, Inc. d.b.a LUPIN recalls GaviLyteTM - C PEG-3350 (240g) and Electrolytes for Oral Solution, USP with Flavor Pack Manufactured by Novel
Sodium Bicarbonate Injection shortage questions
Is Sodium Bicarbonate Injection in shortage?
Yes. Sodium Bicarbonate Injection is on FDA’s drug shortage list (unavailable), last updated Oct 6, 2026.
Why is there a Sodium Bicarbonate Injection shortage?
FDA records the reason as: Demand increase for the drug; Other.
What should I do if I can’t get Sodium Bicarbonate Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.